Comparative evaluation of the effectiveness of spironolactone and eplerenone in patients with chronic heart failure

Baxronova Y.B., Buranova S.N.

dc.contributor.author	Baxronova Y.B., Buranova S.N.
dc.date.accessioned	2023-04-26T05:28:25Z
dc.date.available	2023-04-26T05:28:25Z
dc.date.issued	2023
dc.identifier.citation	Самарканд	en_US
dc.identifier.issn	2181-0974
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/7198
dc.description.abstract	Chronic heart failure (CHF) is a pathophysiological condition in which the heart cannot meet the needs of tissue exchange due to impaired pumping function. According to the results of scientific research conducted in recent years, at least 26 million people are currently suffering from chronic heart failure. Despite the advances in modern medicine in the field of treatment and prevention, mortality and morbidity from this disease is still high. Statistical observations show that the number of patients with CHF will increase by 46% by 2030[2]. Prevention of such a negative growth creates the need for more in-depth research in the field of medicine.	en_US
dc.language.iso	en	en_US
dc.subject	Evaluate comparative efficiency of spirinolactone and eplerenone on neurohumoral parameters in patients with chronic heart failure.	en_US
dc.title	Comparative evaluation of the effectiveness of spironolactone and eplerenone in patients with chronic heart failure	en_US
dc.type	Thesis	en_US